SITC Resource Library

On June 16, 2021, leading experts in cancer immunotherapy presented an advanced webinar focused on "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma." This high-level webinar was designed so that attendees will be able to execute the use of immunotherapy with increased confidence, plan management strategies for difficult cases, and identify and discuss areas of controversy in the immunotherapy field.

Webinar Faculty:

• Moderator: Madhav Dhodapkar, MD — Winship Cancer Institute, Emory University (Expert Panel Chair)
• Amrita Krishnan, MD — Judy and Bernard Briskin Multiple Myeloma Center for Clinical Research, City of Hope Comprehensive Cancer Center (Expert Panel Member)
• Ravi Vij, MD, MBA — Washington University School of Medicine in St. Louis (Expert Panel Member)

• Determining if and when CAR T cell therapy is appropriate in treatment sequencing
• Recognizing, grading and managing CAR T toxicities including CRS and ICANS
• COVID-19 considerations for multiple myeloma patients

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org.